Operating Income (Loss) in USD of BioAge Labs, Inc. from Q3 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BioAge Labs, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q3 2023 to Q3 2025.
  • BioAge Labs, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$23.1M, a 6.51% increase year-over-year.
  • BioAge Labs, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$89.7M.
  • BioAge Labs, Inc. annual Operating Income (Loss) for 2024 was -$78.2M, a 61.6% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BioAge Labs, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$89.7M -$23.1M +$1.61M +6.51% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$91.3M -$24.8M -$9.5M -62.2% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 -$81.8M -$16.4M -$3.63M -28.4% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025
Q4 2024 -$78.2M -$25.4M 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025
Q3 2024 -$24.8M -$14.9M -150% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$15.3M 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 -$12.8M 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025
Q3 2023 -$9.89M 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024

BioAge Labs, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$78.2M -$29.8M -61.6% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025
2023 -$48.4M 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.